Want to see JP:7600 full AI Analyst Report?
Japan Medical Dynamic Marketing, Inc. (7600) AI Stock Analysis
Japan Medical Dynamic Marketing, Inc.
(TSE/TYO:7600)
The score is held back primarily by deteriorating cash flow (deeply negative free cash flow and weak operating cash flow) and weakened operating performance (revenue decline and major margin compression). Technicals add additional pressure due to a clear downtrend and bearish momentum, with only an oversold RSI providing limited offset. Valuation is mixed: a moderate dividend yield helps, but the negative P/E underscores earnings uncertainty.
Japan Medical Dynamic Marketing, Inc. (7600) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 11.91B
- Dividend Yield
- 3.76%
- Average Volume (3M)
- 276.93K
- Price to Earnings (P/E)
- -54.0
- Beta (1Y)
- 0.91
- Revenue Growth
- -8.68%
- EPS Growth
- -75.03%
- Country
- Japan
- Employees
- 539
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
Japan Medical Dynamic Marketing, Inc. Business Overview & Revenue Model
Company Description
Japan Medical Dynamic Marketing, Inc. (JMDM) engages in the development, production, importation, and distribution of medical instruments throughout Japan and the United States. Its product portfolio features a variety of trauma devices, including su...
How the Company Makes Money
The company primarily generates revenue through the sale and distribution of medical devices and related healthcare products to customers such as hospitals, clinics, and other medical institutions. Revenue is typically recognized from product sales (...
Japan Medical Dynamic Marketing, Inc. Financial Statement Overview
Summary
Overall fundamentals have weakened. Income statement trends show revenue turning negative in 2026 and sharp margin compression (net margin ~1.1%, operating margin ~2.4%), despite returning to profitability after a 2025 loss. The balance sheet is generally solid with manageable leverage (debt/equity ~0.23), but returns on equity are very low (~1.0%). The biggest concern is cash flow: operating cash flow fell sharply and free cash flow was deeply negative in 2026 after already being negative in 2025, indicating deteriorating earnings quality and higher funding needs.
Income Statement
52NeutralBalance Sheet
63PositiveCash Flow
34Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.32B | 23.92B | 25.11B | 23.18B | 21.31B | 19.19B |
| Gross Profit | 12.00B | 12.74B | 15.65B | 14.76B | 13.99B | 12.99B |
| EBITDA | 1.62B | 2.19B | 1.40B | 3.27B | 3.35B | 4.21B |
| Net Income | -220.55M | 263.14M | -461.80M | 1.27B | 1.42B | 2.14B |
Balance Sheet | ||||||
| Total Assets | 35.38B | 35.68B | 33.83B | 31.49B | 29.43B | 27.34B |
| Cash, Cash Equivalents and Short-Term Investments | 2.56B | 3.11B | 3.18B | 2.32B | 2.80B | 2.59B |
| Total Debt | 6.63B | 5.87B | 3.29B | 1.49B | 1.87B | 1.85B |
| Total Liabilities | 10.55B | 10.25B | 9.09B | 5.88B | 6.14B | 5.85B |
| Stockholders Equity | 24.81B | 25.40B | 24.68B | 25.51B | 23.16B | 21.39B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -1.75B | -504.10M | 302.45M | 870.67M | 1.53B |
| Operating Cash Flow | 0 | 205.55M | 1.05B | 2.10B | 2.19B | 3.11B |
| Investing Cash Flow | 0 | -2.00B | -1.67B | -1.80B | -1.48B | -1.75B |
| Financing Cash Flow | 0 | 1.65B | 1.49B | -840.71M | -514.78M | -1.29B |
Japan Medical Dynamic Marketing, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7600, the sentiment is Negative. The current price of 452.00 is below the 20-day moving average (MA) of 597.75, below the 50-day MA of 651.30, and below the 200-day MA of 674.12, indicating a bearish trend. The MACD of -35.37 indicates Positive momentum. The RSI at 16.28 is Positive, neither overbought nor oversold. The STOCH value of 3.56 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7600.
Japan Medical Dynamic Marketing, Inc. Peers Comparison
Overall Rating
JP:667882Outperform
JP:684962Neutral
JP:652358Neutral
JP:454950Neutral- JP:760047Neutral
JP:777946Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:6678 | 82Outperform | JPY 18.37B | 11.99 | ― | 5.98% | 20.88% | 44.61% |
| JP:6849 | 62Neutral | JPY 260.18B | 19.34 | ― | 1.93% | 1.43% | 1.86% |
| JP:6523 | 58Neutral | JPY 180.04B | 18.66 | 5.76% | 2.90% | 3.04% | -19.26% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| JP:4549 | 50Neutral | JPY 72.23B | 39.41 | ― | 2.55% | 3.92% | -52.01% |
| JP:7600 | 47Neutral | JPY 14.54B | -54.00 | ― | 3.76% | -8.68% | -75.03% |
| JP:7779 | 46Neutral | JPY 40.75B | 140.00 | 0.69% | ― | -8.42% | ― |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7600 | Japan Medical Dynamic Marketing, Inc. | 452.00 | -28.47 | -5.92% | |
| JP:7779 | CYBERDYNE | 193.00 | 14.00 | 7.82% | |
| JP:6523 | PHC Holdings Corp. | 1450.00 | 455.50 | 45.80% | |
| JP:4549 | Eiken Chemical Co., Ltd. | 2278.00 | 16.08 | 0.71% | |
| JP:6678 | Techno Medica Co., Ltd. | 2192.00 | 379.95 | 20.97% | |
| JP:6849 | Nihon Kohden Corporation | 1657.50 | -5.15 | -0.31% |
Japan Medical Dynamic Marketing, Inc. Corporate Events
Japan Medical Marketing Announces Management Cuts and Business Improvement Plan
Japan Medical Dynamic Marketing operates in the orthopedic medical-device industry, supplying trauma and spine products in Japan and the United States. Its market focus includes priority customers, new product adoption and recovery of procedure volum...
Japan Medical Dynamic Marketing Reports Interim Loss and Withdraws Dividend
Japan Medical Dynamic Marketing is a medical-device company focused on orthopedic products, including joint-replacement systems, with operations in Japan and the United States. Its business is exposed to hospital adoption trends, product competitiven...
Japan Medical Dynamic Marketing Swings to Interim Loss as Sales Decline
Japan Medical Dynamic Marketing, Inc. is a Tokyo-listed medical-device marketing company, although the release does not detail its product portfolio or market focus. For the six months ended September 30, 2026, consolidated sales fell 10.1% year over...
Japan Medical Dynamic Marketing Cuts U.S. Workforce to Bolster Profitability
Japan Medical Dynamic Marketing, Inc. has launched cost-cutting measures at its U.S. subsidiary Ortho Development Corporation, driven by declining net sales and the need to strengthen its earnings base. The subsidiary will undergo an organizational r...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 09, 2026